Home › Funds › Royce & Associates › EVH
Royce & Associates position in EVH
EVOLENT HEALTH INC · Consumer Discretionary
Latest position (Q2 2025)663.01K sh
Reported value held$7.47M
Portfolio Weight0.08%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 310.04K | $9.61M | New |
| Q3 2024 | 250.00K | $7.07M | New |
| Q4 2024 | 576.20K | $6.48M | Add |
| Q1 2025 | 570.88K | $5.41M | Reduce |
| Q2 2025 | 663.01K | $7.47M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EVH
- Morgan Stanley 8.97M sh · $48.61M · Q2 2026
- Vanguard Group 8.91M sh · $35.66M · Q4 2025
- UBS Group AG 6.25M sh · $33.85M · Q2 2026
- Marshall Wace 3.41M sh · $18.50M · Q2 2026
- Geode Capital Management 2.90M sh · $15.75M · Q2 2026
- D. E. Shaw & Co 20.18M sh · $14.92M · Q2 2026
- Charles Schwab Investment Management 2.13M sh · $11.55M · Q2 2026
- Two Sigma Investments 1.26M sh · $6.85M · Q2 2026
- BlackRock Inc 7.58M sh · $5.61M · Q2 2026
- Northern Trust Corp 1.00M sh · $5.44M · Q2 2026
- Bank of America Corp 875.40K sh · $4.74M · Q2 2026
- AQR Capital Management 792.77K sh · $4.30M · Q2 2026